Top Markets
Coin of the day
CellSeed Inc. CellSeed Inc.

CellSeed Inc.

7776
Rank in Stocks #24574
CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell... CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell sheet technology. The company is deeply involved in the research, development, and market introduction of advanced cell-sheet medicine products. Its innovations encompass epithelial cell sheets for repairing the esophagus, as well as both regenerated cartilage sheets and chondrocyte sheets aimed at addressing knee osteoarthritis. Beyond its therapeutic pipeline, CellSeed manufactures and distributes a range of specialized cell cultureware. This includes UpCell, a temperature-responsive cultureware vital for cell-sheet engineering; RepCell, another temperature-sensitive product designed for efficient cell collection; and HydroCell, distinguished by its low cell-binding properties. The firm also provides supporting equipment, such as ThermoPlate III, a heating element constructed from transparent glass, and cellZscope, an automated system for real-time cell monitoring. Additionally, CellSeed offers contract development and manufacturing services. Founded in 2001, the company's main operations are situated in Tokyo, Japan.
Share Price
$1.52
Market Cap
$59.10M
Change (1 day)
-0.85%
Change (1 year)
-51.30%
Country
JP
Trade CellSeed Inc. (7776)

Category

Stock price history for CellSeed Inc. (7776)
Highest end of day price: $1.52 on 2026-08-01

Lowest end of day price: $15.10 on 2010-03-01
Stock price history of CellSeed Inc. from 2010 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 26.43%
2025 -43.74%
2024 53.22%
2023 86.78%
2022 -40.14%
2021 -29.70%
2020 -48.85%
2019 -31.24%
2018 62.73%
2017 -9.39%
2016 -20.99%
2015 -32.19%
2014 -52.50%
2013 121.24%
2012 -18.42%
2011 6.51%
2010 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$549.84 38.34%
US
$1.05K 58.20%
NL
$150.50 473.99%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH